CompletedNCT00566150
Levetiracetam or placebo added to treatment for bipolarity depression
About this title
Read the official source — NCT00566150Medication studyAges 18–65United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- New HavenSee all locations and recruitment
Study information
Study start dateOctober 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 35
- Sponsor
- Yale University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00566150
- Official title
Show the full official title
Levetiracetam in the Management of Bipolar Depression
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Yale University, a university.
Did this study involve medication?
Yes. The study involved medication, including Levetiracetam and Placebo.
Who was this study for?
Listed age limits: 18 years to 65 years.
